Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$74.9BHealthcare Market cap, Sector
Vertex Pharmaceuticals
VRTX$121.87BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 70 VRTX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO7wins
0winsVRTX
84B
C64
87A
C66
92A
B70
66C
C61
75B
D55
91A
C67
95A
C65
Side-by-side metrics
| Metric | JSLL.BO | VRTX |
|---|---|---|
| Market cap | $74.9B | $121.87B Winner |
| P/E (TTM) | 33.2x | 26.2x Winner |
| EV/EBIT | 24.1x | 23.1x Winner |
| ROIC (TTM) | Winner: 39.15% | 17.74% |
| Gross margin | Winner: 88.58% | 86.28% |
| Net margin | 27.68% | 35.4% Winner |
| Revenue CAGR 5y | Winner: 57.81% | 12.37% |
| EPS CAGR 5y | Winner: 86.67% | 14.2% |
| Debt / Equity | 0.3x | 0.1x Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- EPS CAGR 5y86.67%vs 14.2%+84%
- Revenue CAGR 5y57.81%vs 12.37%+79%
- ROIC (TTM)39.15%vs 17.74%+55%
VRTX leads on
- Debt / Equity0.1xvs 0.3x+62%
- Market cap$121.87Bvs $74.9B+39%
- Net margin35.4%vs 27.68%+22%
- P/E (TTM)26.2xvs 33.2x+21%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.